Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Consulting agrmnt
CC transcript

NEUROBIOLOGICAL TECHNOLOGIES INC (NTII) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/03/2019 8-K Other Events
12/23/2015 8-K Other Events
12/17/2012 8-K Quarterly results
12/17/2009 8-K Form 8-K - Current report
12/07/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
11/23/2009 8-K Form 8-K - Current report
10/28/2009 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Departure of Directors or C...
Docs: "Amendment to the Amended and Restated Bylaws of Neurobiological Technologies, Inc",
"Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and Dissolution"
09/17/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Neurobiological Technologies Receives Nasdaq Closing Bid Price Notification"
08/31/2009 8-K Form 8-K - Current report
08/12/2009 8-K Termination of a Material Definitive Agreement
06/15/2009 8-K Termination of a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Termination Agreement, between Neurobiological Technologies, Inc. and Buck Institute for Age Research"
06/02/2009 8-K Form 8-K -- Current report
03/18/2009 8-K Form 8-K -- Current report
02/05/2009 8-K/A Form 8-K/A -- Current report [amend]
02/04/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO"
02/02/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Resignation letter from Paul E. Freiman"
01/15/2009 8-K Form 8-K -- Current report
01/07/2009 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/17/2008 8-K Form 8-K -- Current report
11/06/2008 8-K Quarterly results
Docs: "NEUROBIOLOGICAL TECHNOLOGIES, INC. REPORTS FIRST QUARTER FISCAL YEAR 2009 FINANCIAL RESULTS"
10/14/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data"
09/16/2008 8-K Quarterly results
Docs: "NEUROBIOLOGICAL TECHNOLOGIES, INC. REPORTS FOURTH QUARTER"
08/13/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex Phase 3 Stroke Trials"
07/02/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
06/05/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
05/12/2008 8-K Quarterly results
Docs: "Neurobiological Technologies Reports Third Quarter Financial Results"
04/03/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Offer Letter executed by the Company and Matthew M. Loar"
03/07/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation slides posted on the Company's Internet website on March 7, 2008"
03/05/2008 8-K Entry into a Material Definitive Agreement
02/25/2008 8-K Entry into a Material Definitive Agreement
02/19/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Letter Agreement, between the Company and Craig W. Carlson"
02/11/2008 8-K Quarterly results
Docs: "Neurobiological Technologies Reports Second Quarter Financial Results"
12/20/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/05/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Buck Institute and Neurobiological Technologies, Inc. Partner to Develop Treatment for Huntington's Disease"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy